A Study to Evaluate How Well Single and Multiple Doses of GLPG3121-modified Release Formulation Are Tolerated in Healthy, Adult Subjects
Clinical trial NCT04856358 · COMPLETED
Trial details
- NCT number
- NCT04856358
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-27
- Primary completion
- 2021-11-08
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.